Literature DB >> 28288828

Functional interrogation of non-coding DNA through CRISPR genome editing.

Matthew C Canver1, Daniel E Bauer2, Stuart H Orkin3.   

Abstract

Methodologies to interrogate non-coding regions have lagged behind coding regions despite comprising the vast majority of the genome. However, the rapid evolution of clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing has provided a multitude of novel techniques for laboratory investigation including significant contributions to the toolbox for studying non-coding DNA. CRISPR-mediated loss-of-function strategies rely on direct disruption of the underlying sequence or repression of transcription without modifying the targeted DNA sequence. CRISPR-mediated gain-of-function approaches similarly benefit from methods to alter the targeted sequence through integration of customized sequence into the genome as well as methods to activate transcription. Here we review CRISPR-based loss- and gain-of-function techniques for the interrogation of non-coding DNA.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28288828      PMCID: PMC5483188          DOI: 10.1016/j.ymeth.2017.03.008

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  204 in total

Review 1.  When needles look like hay: how to find tissue-specific enhancers in model organism genomes.

Authors:  Maximilian Haeussler; Jean-Stéphane Joly
Journal:  Dev Biol       Date:  2010-12-03       Impact factor: 3.582

2.  Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors.

Authors:  Zachary Steinhart; Zvezdan Pavlovic; Megha Chandrashekhar; Traver Hart; Xiaowei Wang; Xiaoyu Zhang; Mélanie Robitaille; Kevin R Brown; Sridevi Jaksani; René Overmeer; Sylvia F Boj; Jarrett Adams; James Pan; Hans Clevers; Sachdev Sidhu; Jason Moffat; Stéphane Angers
Journal:  Nat Med       Date:  2016-11-21       Impact factor: 53.440

3.  A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.

Authors:  Ryan J Park; Tim Wang; Dylan Koundakjian; Judd F Hultquist; Pedro Lamothe-Molina; Blandine Monel; Kathrin Schumann; Haiyan Yu; Kevin M Krupzcak; Wilfredo Garcia-Beltran; Alicja Piechocka-Trocha; Nevan J Krogan; Alexander Marson; David M Sabatini; Eric S Lander; Nir Hacohen; Bruce D Walker
Journal:  Nat Genet       Date:  2016-12-19       Impact factor: 38.330

4.  Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells.

Authors:  Yunqing Ma; Jiayuan Zhang; Weijie Yin; Zhenchao Zhang; Yan Song; Xing Chang
Journal:  Nat Methods       Date:  2016-10-10       Impact factor: 28.547

5.  A mechanism for the suppression of homologous recombination in G1 cells.

Authors:  Alexandre Orthwein; Sylvie M Noordermeer; Marcus D Wilson; Sébastien Landry; Radoslav I Enchev; Alana Sherker; Meagan Munro; Jordan Pinder; Jayme Salsman; Graham Dellaire; Bing Xia; Matthias Peter; Daniel Durocher
Journal:  Nature       Date:  2015-12-09       Impact factor: 49.962

6.  A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response.

Authors:  Britt Adamson; Thomas M Norman; Marco Jost; Min Y Cho; James K Nuñez; Yuwen Chen; Jacqueline E Villalta; Luke A Gilbert; Max A Horlbeck; Marco Y Hein; Ryan A Pak; Andrew N Gray; Carol A Gross; Atray Dixit; Oren Parnas; Aviv Regev; Jonathan S Weissman
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

7.  Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.

Authors:  Patrick Essletzbichler; Tomasz Konopka; Federica Santoro; Doris Chen; Bianca V Gapp; Robert Kralovics; Thijn R Brummelkamp; Sebastian M B Nijman; Tilmann Bürckstümmer
Journal:  Genome Res       Date:  2014-11-04       Impact factor: 9.043

8.  Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9.

Authors:  Shota Nakade; Takuya Tsubota; Yuto Sakane; Satoshi Kume; Naoaki Sakamoto; Masanobu Obara; Takaaki Daimon; Hideki Sezutsu; Takashi Yamamoto; Tetsushi Sakuma; Ken-ichi T Suzuki
Journal:  Nat Commun       Date:  2014-11-20       Impact factor: 14.919

9.  Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.

Authors:  Jianbin Wang; Colin M Exline; Joshua J DeClercq; G Nicholas Llewellyn; Samuel B Hayward; Patrick Wai-Lun Li; David A Shivak; Richard T Surosky; Philip D Gregory; Michael C Holmes; Paula M Cannon
Journal:  Nat Biotechnol       Date:  2015-11-09       Impact factor: 54.908

10.  An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.

Authors:  Yotam Drier; Matthew J Cotton; Kaylyn E Williamson; Shawn M Gillespie; Russell J H Ryan; Michael J Kluk; Christopher D Carey; Scott J Rodig; Lynette M Sholl; Amir H Afrogheh; William C Faquin; Lurdes Queimado; Jun Qi; Michael J Wick; Adel K El-Naggar; James E Bradner; Christopher A Moskaluk; Jon C Aster; Birgit Knoechel; Bradley E Bernstein
Journal:  Nat Genet       Date:  2016-02-01       Impact factor: 38.330

View more
  12 in total

1.  Integrated design, execution, and analysis of arrayed and pooled CRISPR genome-editing experiments.

Authors:  Matthew C Canver; Maximilian Haeussler; Daniel E Bauer; Stuart H Orkin; Neville E Sanjana; Ophir Shalem; Guo-Cheng Yuan; Feng Zhang; Jean-Paul Concordet; Luca Pinello
Journal:  Nat Protoc       Date:  2018-04-12       Impact factor: 13.491

Review 2.  CRISPR Tools for Systematic Studies of RNA Regulation.

Authors:  Jesse Engreitz; Omar Abudayyeh; Jonathan Gootenberg; Feng Zhang
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

Review 3.  Transcriptional enhancers at 40: evolution of a viral DNA element to nuclear architectural structures.

Authors:  Sreejith J Nair; Tom Suter; Susan Wang; Lu Yang; Feng Yang; Michael G Rosenfeld
Journal:  Trends Genet       Date:  2022-07-07       Impact factor: 11.821

Review 4.  CRISPR/Cas9-mediated noncoding RNA editing in human cancers.

Authors:  Jie Yang; Xiaodan Meng; Jinchang Pan; Nan Jiang; Chengwei Zhou; Zhenhua Wu; Zhaohui Gong
Journal:  RNA Biol       Date:  2017-11-09       Impact factor: 4.652

Review 5.  Prospects of Non-Coding Elements in Genomic DNA Based Gene Therapy.

Authors:  S P Simna; Zongchao Han
Journal:  Curr Gene Ther       Date:  2022       Impact factor: 4.676

6.  Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies.

Authors:  Constantinos C Loucari; Petros Patsali; Thamar B van Dijk; Coralea Stephanou; Panayiota Papasavva; Maria Zanti; Ryo Kurita; Yukio Nakamura; Soteroulla Christou; Maria Sitarou; Sjaak Philipsen; Carsten W Lederer; Marina Kleanthous
Journal:  Hum Gene Ther Methods       Date:  2018-02       Impact factor: 2.396

Review 7.  Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review).

Authors:  Diana Raquel Rodríguez-Rodríguez; Ramiro Ramírez-Solís; Mario Alberto Garza-Elizondo; María De Lourdes Garza-Rodríguez; Hugo Alberto Barrera-Saldaña
Journal:  Int J Mol Med       Date:  2019-02-26       Impact factor: 4.101

Review 8.  The genetics of human hematopoiesis and its disruption in disease.

Authors:  Erik L Bao; Aaron N Cheng; Vijay G Sankaran
Journal:  EMBO Mol Med       Date:  2019-07-17       Impact factor: 12.137

9.  DMSO increases efficiency of genome editing at two non-coding loci.

Authors:  George Stratigopoulos; Maria Caterina De Rosa; Charles A LeDuc; Rudolph L Leibel; Claudia A Doege
Journal:  PLoS One       Date:  2018-06-04       Impact factor: 3.240

Review 10.  CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.

Authors:  Somali Chaterji; Eun Hyun Ahn; Deok-Ho Kim
Journal:  Theranostics       Date:  2017-10-07       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.